Glia Innovation is a Brazilian hub for cosmetic innovation, providing advanced nanotechnological solutions and biomimetic peptides to enhance the performance and efficacy of personal care and dermocosmetic products for industrial and pharmacy clients.
Glia Innovation is a Brazilian biotechnology company specializing in the development of advanced nanotechnologies and biomimetic peptides for the cosmetics and dermocosmetics industries. Formed in 2022 through the merger of Nanoceuticals and PlateInnove, the company focuses on creating high-performance active ingredients. Its technology leverages nanocarriers to encapsulate active compounds, which enhances skin penetration and overall product efficacy. The company operates as an innovation hub, combining scientific research with industrial application to develop specialized solutions for hair, face, and body care products.
The company serves a diverse client base, including cosmetics manufacturers and compounding pharmacies, helping them improve product performance through science-driven innovation. By providing specialized raw materials, Glia supports brands in creating premium, high-value personal care products. Their commitment to international standards is evidenced by regulatory achievements, such as the inclusion of their proprietary Eris peptide in the European Union's cosmetic ingredient inventory. Headquartered in Goiânia, Goiás, Glia Innovation maintains an active presence in the Brazilian market and is expanding its distribution network internationally to include regions such as the United States, India, and Poland.